CH12'CL, ANTI-SHEEP AND CHICKEN RBC
11-50'CL, ANTI-LACTOTETRAOSYLCERAMIDE
CH9'CL, ANTI-BROMELAIN-TREATED MOUSE ERYTHROCYTES
X211'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
2D3'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
AZ-3'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
A9'CL, ANTI-GP41
AZ-20'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
33.1.C2'CL, ANTI-CD5
L25'CL, AUTOANTIBODY
129, ANTI-PHOSPHOTYROSYLPROTEIN
WO1'CL, ANTI-GM1 GANGLIOSIDE
3-9'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
120, ANTI-MICROCOCCUS LYSODEIKTICUS
36.2.2'CL, ANTI-STREPTOCOCCAL M PROTEIN, MYOSIN, LIGHT MEROMYOSIN, TROPOMYOSIN, KERATIN
ITC33'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
MGC23'CL, ANTI-NUCLEOSOME
HUM1A1L1'CL, KIM11.4
1F5.D1'CL, ANTI-HORSE CYTOCHROME C HYBRIDOMA
NZA2'CL, ANTI-NUCLEOSOME
N25'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
L42'CL, AUTOANTIBODY
AL3-7'CL, ANTI-POLYCATION
B/SB5-18'CL, ANTI-H2A/H2B
F2'CL, ANTI-MELANOMA
cAbAMD7, ANTI-ALPHA-AMYLASE
BMA 031 VL'CL, HUMAN TCR-ALPHA/BETA
h60.3'CL, ANTI-CD18
Ha1'CL, ANTI-DISIALOSYL
HB4C5'CL, ANTI-HUMAN LUNG ADENOCARCINOMA
BR1'CL, ANTI-GM1 GANGLIOSIDE
2E1'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
AL3-6'CL, ANTI-POLYCATION
129-48'CL, ANTI-IGG HYBRIDOMA
D444'CL, ANTI-RNA AUTOANTIBODY, ANTI-POLY(G,C) HYBRIDOMA
FK-001'CL, ANTI-PSEUDOMONAS AERUGINOSA EXOTOXIN A HYBRIDOMA
64-32E4, ANTI-ARS
1-30'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
CH12'CL, ANTI-SHEEP AND CHICKEN RBC
D06, ANTI-LYSOZYME HYBRIDOMA
11-50'CL, ANTI-LACTOTETRAOSYLCERAMIDE
CH9'CL, ANTI-BROMELAIN-TREATED MOUSE ERYTHROCYTES
Y2''CL, ANTI-SM HYBRIDOMA
2E5.G10'CL, ANTI-RAT CYTOCHROME C HYBRIDOMA
X211'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
2D3'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
AZ-3'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
A9'CL, ANTI-GP41
AZ-20'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
1-12'CL, ANTI-SM HYBRIDOMA
3-56'CL, ANTI-SM HYBRIDOMA
L25'CL, AUTOANTIBODY
129, ANTI-PHOSPHOTYROSYLPROTEIN
T10-938'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
WO1'CL, ANTI-GM1 GANGLIOSIDE
3-9'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
120, ANTI-MICROCOCCUS LYSODEIKTICUS
36.2.2'CL, ANTI-STREPTOCOCCAL M PROTEIN, MYOSIN, LIGHT MEROMYOSIN, TROPOMYOSIN, KERATIN
ITC33'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
MGC23'CL, ANTI-NUCLEOSOME
1F5.D1'CL, ANTI-HORSE CYTOCHROME C HYBRIDOMA
5B5'CL, ANTI-SM HYBRIDOMA
NZA2'CL, ANTI-NUCLEOSOME
7-13'CL, ANTI-SM HYBRIDOMA
G01, ANTI-LYSOZYME HYBRIDOMA
N25'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
BC-1004'CL, ANTI-BLOOD GROUP B SUBSTANCE HYBRIDOMA
L42'CL, AUTOANTIBODY
B04, ANTI-LYSOZYME HYBRIDOMA
AL3-7'CL, ANTI-POLYCATION
B/SB5-18'CL, ANTI-H2A/H2B
1-8'CL, ANTI-SM HYBRIDOMA
cAbAMD7, ANTI-ALPHA-AMYLASE
BMA 031 VL'CL, HUMAN TCR-ALPHA/BETA
h60.3'CL, ANTI-CD18
Ha1'CL, ANTI-DISIALOSYL
HB4C5'CL, ANTI-HUMAN LUNG ADENOCARCINOMA
BR1'CL, ANTI-GM1 GANGLIOSIDE
2E1'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
AL3-6'CL, ANTI-POLYCATION
129-48'CL, ANTI-IGG HYBRIDOMA
D444'CL, ANTI-RNA AUTOANTIBODY, ANTI-POLY(G,C) HYBRIDOMA
FK-001'CL, ANTI-PSEUDOMONAS AERUGINOSA EXOTOXIN A HYBRIDOMA
25C10, ANTI-LYSOZYME HYBRIDOMA
64-32E4, ANTI-ARS
1-30'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
